About this trial
Familial mediterranean fever (FMF) is common in mediterranean region. this disorder is connected with deterioration in functional performance, fitness of cardiorespiration, muscle strength, and bone mass
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
whole body vibration plus usual care
Other interventionFamilial mediterranean fever (20 FMF adolescent girls ) will be in this vibration group who will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will also receive three sessions of 20-min whole body vibration in the week for 6 months
usual care
Other interventionFamilial mediterranean fever (20 FMF adolescent girls ) will be in this control group who will receive vitamin D and their traditional colchicine doses daily for six months.
Treatment groups
Trial outcomes
Primary outcomes
bone mineral density
it is a measure for bone density at 2-4 lumbar vertebrae
Secondary outcomes
z score
it is a score for measure for bone mass at 2-4 lumbar vertebrae
vitamin D
it will measured in plasma as serum 25-hydroxyvitamin D
osteoprotegerin
it will measured in plasma
quadriceps torque
it will measured in dominant side
Sponsors and contacts
Click on the lead sponsor to view all of their trials.